Instylla, Inc. announced premarket approval (PMA) from the FDA for the company’s flagship Embrace hydrogel embolic system.

HistoSonics, the developer of the Edison histotripsy system and histotripsy therapy platform, announced a management-led majority ...

Royal Philips recently announced FDA 510(k) clearance of the latest version of the company’s UroNav system for image-guided ...

The Society of Interventional Oncology (SIO) recently announced the completion of enrollment for its clinical trial, ...

Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, announced ...

AngioDynamics, Inc. announced enrollment of the first patient in the AMBITION BTK study of the Auryon atherectomy system.

Inari Medical, now part of Stryker, announced the launch of its next-generation InThrill thrombectomy system. According to ...

Embolx, a developer of microcatheters for targeted embolization procedures, announced the market release of its ...

Cook Medical announced the launch of its Interventional MRI (iMRI) division, which will collaborate with physicians, ...

Vexev and U.S. Renal Care announced the completion of enrollment in the CANSCAN clinical trial, a multicenter feasibility s ...

Access to better care, rapid intervention, and standardized procedures with predictable outcomes is critical for treating ...

The evolution of reimbursement models, the challenge of budget neutrality mandates and decreasing reimbursements in the ...